Efficiency and safety of hepatic arterial infusion chemotherapy (HAIC) combined with anti-PD1 therapy versus HAIC monotherapy for advanced hepatocellular carcinoma: A multicenter propensity score matching analysis.

Yangyang LiWendao LiuJunwei ChenYongxin ChenJiandong GuoHuajin PangWentao ZhangChao AnChengzhi Li

Published in: Cancer medicine (2024)

The combination therapy of HAIC and PD1 inhibitors successfully extended OS to advanced HCC patients and could be a better choice than HAIC monotherapy.

Keyphrases

combination therapy
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
radiation therapy
stem cells
mesenchymal stem cells
bone marrow
patient reported